Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 722-733.e11
Open Access | Times Cited: 480

Showing 26-50 of 480 citing articles:

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Yunlong Cao, Ayijiang Yisimayi, Yali Bai, et al.
Cell Research (2021) Vol. 31, Iss. 7, pp. 732-741
Open Access | Times Cited: 153
COVID-19 vaccine: where are we now and where should we go?
Saman Soleimanpour, Atieh Yaghoubi
Expert Review of Vaccines (2021) Vol. 20, Iss. 1, pp. 23-44
Open Access | Times Cited: 145
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
Kefang Liu, Xiaoqian Pan, Linjie Li, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3438-3451.e10
Open Access | Times Cited: 135
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
Integrated gut virome and bacteriome dynamics in COVID-19 patients
Yīmíng Bào, Cheng Wang, Yuqing Zhang, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 123
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu, Ping Gao, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2265-2278.e14
Open Access | Times Cited: 113
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 87
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
Yaling An, Shihua Li, Xiyue Jin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1058-1071
Open Access | Times Cited: 81
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
An engineered bispecific human monoclonal antibody against SARS-CoV-2
Zhaohui Li, Shihua Li, Gen Zhang, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 423-430
Open Access | Times Cited: 69
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
Brittany L. Hartwell, Mariane B. Melo, Peng Xiao, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 654
Open Access | Times Cited: 67
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Jiawei Zeng, Yao Li, Linrui Jiang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 40
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Pathogens and planetary change
Colin J. Carlson, Cole B. Brookson, Daniel J. Becker, et al.
(2025) Vol. 1, Iss. 1, pp. 32-49
Closed Access | Times Cited: 3
A COVID-19 Vaccine: Big Strides Come with Big Challenges
Juanita Mellet, Michael S. Pepper
Vaccines (2021) Vol. 9, Iss. 1, pp. 39-39
Open Access | Times Cited: 99
Particulate Alum via Pickering Emulsion for an Enhanced COVID‐19 Vaccine Adjuvant
Sha Peng, Fengqiang Cao, Yufei Xia, et al.
Advanced Materials (2020) Vol. 32, Iss. 40
Open Access | Times Cited: 95
SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination
Wei‐Chiao Huang, Shiqi Zhou, Xuedan He, et al.
Advanced Materials (2020) Vol. 32, Iss. 50
Open Access | Times Cited: 93
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 88
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108162-108162
Open Access | Times Cited: 86
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
Wenjun Wang, Baoying Huang, Yanping Zhu, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 749-751
Open Access | Times Cited: 84

Scroll to top